Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SpineThera, Inc., a clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain) and ProMed Pharma ...
read more
Cambrex announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.
read more
Wednesday, March 13, 2024
Allumiqs and Prolytix, announced a long-term, strategic partnership focused on delivering collaborative and integrated solutions to help customers optimize drug development pipelines.
read more
Tuesday, February 20, 2024
National Resilience, Inc. (Resilience) announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network. By scaling this capacity, Resilience aims to provide over 200 million units to its ...
read more
Tuesday, February 13, 2024
Catalent, Inc. and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, announced that they have entered into a merger agreement under which Novo Holdings will acquire ...
read more
Wednesday, January 31, 2024
WuXi Biologics announced the successful completion of the first manufacturing run at its drug substance facility MFG7, paving the way for large-scale commercial manufacturing projects at this Ireland site.
read more
Thursday, December 07, 2023
Experic, a contract development and manufacturing organization (CDMO) and provider of clinical trial supply services, has unveiled the incorporation of a Harro Höfliger Modu-C CS Containment system at its New Jersey facility.
read more
Thursday, November 16, 2023
Eurofins, a prominent provider of testing services for food, environment, pharmaceuticals, cosmetics, and various research disciplines such as discovery pharmacology, forensics, advanced material sciences, and agroscience contract research, has ...
read more
According to DataHorizzon Research, the Active Pharmaceutical Ingredients (API) Market size was valued at USD 151.2 Billion in 2022 and is expected to reach USD 346.4 Billion by 2032 at a CAGR of 8.7%.
read more
Thursday, October 19, 2023
As of November 1st, 2023, Dr. Stephan Haitz will assume the role of President of the Novasep CDMO Business Unit and will become a member of the company's Executive Committee, succeeding Jean Bléhaut, who is departing the company after a distinguished...
read more
Willow Biosciences Inc., (“Willow”) and SUANFARMA today jointly announced execution of a collaboration agreement for a cell line productivity optimization development program for
manufacturing a large volume anti-infective Active Pharmaceutical ...
read more
Croda broke ground on 9 May 2023 on its newest manufacturing facility in Lamar, Clinton County, Pennsylvania.
read more
ASM Research Chemicals, a contract research and development services provider specialized in organic chemistry, is launching its new development pack (referred to as DevPack) service intended for active pharmaceutical ingredients (APIs) manufacturing...
read more
Framework Solutions announced the appointment of Russ Belden as Head of Commercial Solutions, effective April 26th, 2023.
read more
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP production of therapeutic antibodies, announced the closing of their Series A financing round.
read more